Canada · Delayed Price · Currency is CAD Biosenta Statistics
Total Valuation
Biosenta has a market cap or net worth of CAD 3.02 million. The enterprise value is 10.52 million.
| Market Cap | 3.02M |
| Enterprise Value | 10.52M |
Important Dates
The next estimated earnings date is Wednesday, January 27, 2027.
| Earnings Date | Jan 27, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Biosenta has 37.73 million shares outstanding. The number of shares has increased by 7.35% in one year.
| Current Share Class | 37.73M |
| Shares Outstanding | 37.73M |
| Shares Change (YoY) | +7.35% |
| Shares Change (QoQ) | -48.00% |
| Owned by Insiders (%) | 13.77% |
| Owned by Institutions (%) | n/a |
| Float | 32.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 827.49 |
| PB Ratio | -0.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -16.26 |
| Interest Coverage | -1.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -766.59% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 11.70% |
| Weighted Average Cost of Capital (WACC) | 9.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.33, so Biosenta's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 56.21 |
| Average Volume (20 Days) | 21,592 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biosenta had revenue of CAD 3,648 and -2.61 million in losses. Loss per share was -0.07.
| Revenue | 3,648 |
| Gross Profit | 1,159 |
| Operating Income | -1.38M |
| Pretax Income | -2.61M |
| Net Income | -2.61M |
| EBITDA | -1.38M |
| EBIT | -1.38M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 19,935 in cash and 7.52 million in debt, with a net cash position of -7.50 million or -0.20 per share.
| Cash & Cash Equivalents | 19,935 |
| Total Debt | 7.52M |
| Net Cash | -7.50M |
| Net Cash Per Share | -0.20 |
| Equity (Book Value) | -11.78M |
| Book Value Per Share | -0.31 |
| Working Capital | -11.82M |
Cash Flow
In the last 12 months, operating cash flow was -461,075 and capital expenditures -1,647, giving a free cash flow of -462,722.
| Operating Cash Flow | -461,075 |
| Capital Expenditures | -1,647 |
| Depreciation & Amortization | 2,221 |
| Net Borrowing | 477,967 |
| Free Cash Flow | -462,722 |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 31.77% |
| Operating Margin | -37,796.98% |
| Pretax Margin | -71,521.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biosenta does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.35% |
| Shareholder Yield | -7.35% |
| Earnings Yield | -86.43% |
| FCF Yield | -15.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.
| Last Split Date | Jun 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.0666666666 |
Scores
Biosenta has an Altman Z-Score of -556.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -556.75 |
| Piotroski F-Score | 1 |